ALX Oncology Holdings Inc. (ALXO) Misses Q3 EPS by 4c

ALX Oncology Holdings Inc. (NASDAQ: ALXO) reported Q3 EPS of ($0.41), $0.04 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on ALX Oncology Holdings Inc. (ALXO) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• Zenas BioPharma (ZBIO) files for up to 7M share offering by selling stockholders
• Hooker Furniture (HOFT) Tops Q2 EPS by 16c, Misses on Revenue